The U.S. Congress and Biden-Harris administration have a clear opportunity to supercharge global R&D in the wake of a pandemic that has revealed both the sector’s chronic neglect and amazing potential, according to a detailed agency-by-agency action plan released today by GHTC.
Learn more
GHTC statement in advance of the World Health Organization (WHO) inaugural forum with non-state actors.
Learn more
GHTC submitted testimony for the public record for a hearing held April 16, 2021 by the House Foreign Affairs Subcommittee on International Organizations and Global Corporate Social Impact titled Innovation in Development Policy: Maximizing Impact and Results.
PDF
GHTC joined letters from the Global Health Council Maternal and Child Health Roundtable to House and Senate Appropriators encouraging robust funding for fiscal year 20211 (FY22) for maternal and child heath and nutrition accounts at the US Agency for International Development.
PDF
As the G20 Health Working Group meets next this Thursday and Friday, GHTC urges them to prioritize several actions to bolster R&D to defeat COVID-19, mitigate its impacts, and combat other long-standing and emerging threats.
Learn more
GHTC statement in advance of the World Health Organization (WHO) inaugural forum with non-state actors.
Learn more
As the G20 Health Working Group meets next this Thursday and Friday, GHTC urges them to prioritize several actions to bolster R&D to defeat COVID-19, mitigate its impacts, and combat other long-standing and emerging threats.
Learn more
The U.S. Congress and Biden-Harris administration have a clear opportunity to supercharge global R&D in the wake of a pandemic that has revealed both the sector’s chronic neglect and amazing potential, according to a detailed agency-by-agency action plan released today by GHTC.
Learn more
GHTC urges Congress to pass a COVID-19 emergency supplemental bill that includes at least $11 billion for global health programs to support the international response to the pandemic, underscoring the need for dedicated funding to USAID and CEPI.
Learn more
GHTC's policy report Meeting the moment, fueling the future: Policy recommendations for a new era of leadership in global health R&D was featured in a news story on LaboratoryEquipment.com.
View
GHTC's policy report Meeting the moment, fueling the future: Policy recommendations for a new era of leadership in global health R&D was features on the website NewsMedical.net.
View
Global Health Now featured a commentary, authored by GHTC Director Jamie Bay Nishi, highlighting key findings from GHTC's report Pain Points and Potential: How COVID-19 is Reshaping Global Health R&D.
View
Devex cited a report released by GHTC assessing the impact of the COVID-19 pandemic on global health R&D.
View
GHTC submitted testimony for the public record for a hearing held April 16, 2021 by the House Foreign Affairs Subcommittee on International Organizations and Global Corporate Social Impact titled Innovation in Development Policy: Maximizing Impact and Results.
PDF
GHTC joined letters from the Global Health Council Maternal and Child Health Roundtable to House and Senate Appropriators encouraging robust funding for fiscal year 20211 (FY22) for maternal and child heath and nutrition accounts at the US Agency for International Development.
PDF
GHTC joined a TB Roundtable letter to the director of the Centers for Disease Control and Prevention (CDC) expressing concern that funding from CDC's Tuberculosis Trials Consortium will be discontinued to four clinical trial sites.
PDF
GHTC endorsed a letter from the TB Roundtable to the White Office of Management and Budget (OMB) providing recommendations for funding funding levels for global tuberculosis programs in the fiscal year 2022 (FY22) budget.
PDF
McGill Summer Institute in Infectious Diseases
Online Courses
View
Marissa Chmiola
Communications Officer
Global Health Technologies Coalition
(202) 540-4414
mchmiola@ghtcoalition.org